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ABSTRAK 
 
 
Terdapat dua kaedah pencampuran darah semasa proses pengumpulan darah, iaitu 
kaedah pencampuran secara manual dan pengadun pengutipan automatik. Tujuan 
pencampuran darah yang dikumpulkan dengan antikoagulan dalam beg utama adalah 
untuk mencegah platelet dan faktor pembekuan awal pengaktifan. Kualiti pati platelet 
mungkin terjejas akibat daripada proses pencampuran yang tidak mencukupi semasa 
pengumpulan darah. Oleh sebab itu, kajian ini dijalankan untuk menilai sama ada 
pencampuran darah secara manual akan menghasilkan kualiti pati platelet yang sama 
degan pengadun pengutipan automatik. Sebanyak 30 peserta yang layak terlibat diri 
dalam kajian ini. Sebanyak 15 unit darah dikumpulkan dengan pengadun pengutipan 
automatik dan 15 unit lagi dikumpulkan melalui kaedah pencampuran manual. Pati 
platelet dihasilkan menggunakan kaedah “platelet rich plasma”. Pati platelet disimpan 
pada suhu 20⁰C hingga 24⁰C, di rak yang bergoyang selama 5 hari. Parameter kawalan 
kualiti seperti jumlah platelet sel, jumlah sel darah putih dan pH diuji pada pati platelet 
pada Hari 1 dan Hari 5. Hasil kajian ini menujukkan semua pati platelet mencapai 
keperluan kualiti yang dikehendaki daripada garis panduan pusat darah negara, dengan 
jumlah sel darah putih kurang daripada 0.2 x 109/unit dan nilai pH lebih daripada 6.4.  
 
 
 
 xvii 
 
 
 
 
Walau bagaimanapun, hanya 27% hingga 40% pati platelet memenuhi keperluan 
standard kebangsaan iaitu bilangan platelet melebihi daripada 60 x 109/unit. Parameter 
jumlah platelet sel menunjukkan perbezaan median yang signifikan (p< 0.05) dari Hari 
1 hingga Hari 5 bagi kedua-dua jenis kaedah pengumpulan darah. Walau 
bagaimanapun, untuk jumlah sel darah putih dan pH tidak menunjukkan perbezaan (p> 
0.05) dari Hari 1 hingga Hari 5 bagi kedua-dua jenis kaedah pengumpulan darah. 
Terdapat tidak ada perbezaan yang signifikan secara statistik (p> 0.05) antara dua jenis 
kaedah pengumpulan darah pada kedua-dua Hari 1 dan Hari 5 untuk semua parameter 
yang diuji. Kesimpulannya, kualiti platelet seperti jumlah platelet, jumlah sel darah 
putih and pH yang dikumpul melalui kaedah pencampuran secara manual adalah serupa 
dengan pengadun pengutipan automatik. 
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A PRELIMINARY STUDY ON PLATELET CONCENTRATES QUALITY 
COLLECTED FROM TWO DIFFERENT MIXING METHODS: MANUAL 
MIXING VERSUS AUTOMATED BLOOD COLLECTION MIXER 
 
 
ABSTRACT 
 
 
There are two different mixing methods used in whole blood collection which are 
manual mixing and automated blood collection mixer. The purpose of mixing collected 
blood with anticoagulant in primary bag is to prevent platelet and clotting factors early 
activation. Platelet concentrates quality might be affected due to inadequate mixing 
process during collection process. Therefore, this study is to evaluate whether manual 
mixing method produces similar quality of platelet concentrates with automated blood 
collection mixer. In this study, total 30 eligible participants were included. 15 units of 
whole blood were mixed by automated blood collection mixer and another 15 units 
were mixed by manual mixing method. Platelet concentrates were produced by using 
platelet rich plasma method. Platelet concentrates were stored at 20⁰C to 24⁰C, 
continuous agitation for 5 days. Quality control parameters such as total platelet count, 
total white blood cell and pH were tested on these platelet concentrates at Day 1 and 
 
 xix 
 
 
 
Day 5. This study result showed all platelet concentrates achieved desired quality 
requirement from National Blood Centre Guideline with total white blood cell less than 
0.2 x 109/unit and pH value more than 6.4. However, only 27% to 40% of the platelet 
concentrates met the national standard requirement in which the platelet counts were 
more than 60x109/unit. Total platelet count parameter showed significant median 
difference (p<0.05) from Day 1 to Day 5 for both types of mixing method. However, 
there were no statistical significant difference (p>0.05) for total white blood cell and pH 
from Day 1 and Day 5 for both types of mixing method. There was no statistically 
significant difference (p>0.05) between two mixing methods at both Day 1 and Day 5 
for all the parameters measured. In conclusion, quality platelet concentrates which are 
total platelet count, total white blood cell and pH collected by manual mixing method 
has similar outcomes with automated blood collection mixer. 
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CHAPTER 1 
INTRODUCTION  
1.1 Background 
1.1.1 Platelet morphology and structure 
Platelet is small discoid anucleated cell, varying from 1 to 4 microns in diameter, which 
has mitochondria, produces and stores adenosine triphosphate and is high sensitive to its 
environment (Thon and Italiano, 2010). The mean volume of platelet cell is 7 to 11 fl, 
and it is the second most abundant corpuscle in the blood after red blood cell. The 
normal concentration of platelets in circulating blood is between 150 and 400 x 109 /L 
(Cardigan et al., 2005;  Hoffbrand and Moss, 2015). Platelet consists of several 
important cell structures, organelles, and antigens. The surface of the platelet is coated 
with glycoproteins molecule, important in platelet activation, adhesion, and aggregation 
which are the initial events for platelet plug formation during primary haemostasis 
process. There are several types of glycoproteins present on the surface of platelet 
which are glycoprotein Ia (GPIa), glycoprotein Ib (GPIb) and glycoprotein IIb/IIIa 
(GPIIb/IIIa). Each glycoprotein plays different roles in haemostatsis process. GPIa is 
directly adhesion to collagen when the vascular endothelium exposed. GPIb and 
GPIIb/IIIa are important in the attachment of platelets to von Willebrand factor (VWF), 
leads to platelet adhesion to subendothelium, platelet attachment and platelet 
aggregation subsequently. Besides, GPIIb/IIIa also plays an important role to activate 
and cross-link with fibrinogen and form a platelet-platelet aggregation. Platelet 
phospholipid membrane is important in the conversion of coagulation factor X to Xa 
and prothrombin (factor II) to thrombin (factor IIa) in common pathway of blood 
coagulation. Platelet consists of three types of storage granules which are dense granule, 
 2 
 
alpha granule, and lysosomes. Each granule contains different substance inside it. Dense 
granules contain adenosine diphosphate (ADP), adenosine triphosphate (ATP), 
serotonin and calcium. Alpha granule is the most frequent granule in platelet, consist of 
proteins such as clotting factors, VWF, platelet-derived growth factor (PDGF) and 
others. Lastly, lysosomes consist of hydrolytic enzymes. During platelet activation, the 
contents of the granules are released into the open canalicular system. The open 
canalicular system is located at plasma membrane of the platelet which forms an 
invaginate into the platelet interior structure and provide a large reactive surface to 
plasma coagulation proteins (Hoffbrand and Moss, 2015). 
Platelet expresses several types of antigens on the surface which are ABO antigen, 
human leukocyte antigen (HLA) class 1 and human platelet antigen (HPA). These 
antigens play an important role in platelet-specific autoimmunity and alloimmunity. 
Each individual consists of two different alleles which are inherited from the parent 
(Hoffbrand and Moss, 2015). For instances, 28 of HPA biallelic groups have been 
recovered since 2003 and these are numbered as HPA-1 to HPA-28. Each gene is 
constructed by 2 different alleles (heterozygosity) or same alleles (homozygosity) 
termed as “a” or “b” alleles (HPA-1a or HPA-1b) (Nadarajan, 2014). Based on Tan et 
al. study, it showed the most common genotype observed among 17% of population in 
Malaysia were HPA-1a/1a, HPA-2a/2a, HPA3a/3b, HPA-4a/4a, HPA-5a/5a, HPA6a/6a 
and HPA-15a/15b. Whereas, 14.33% of Malaysians consist of HPA-1a/1a, HPA-2a/2a, 
HPA-3a/3a, HPA-4a/4a, HPA-5a/5a, HPA-6a/6a and HPA-15a/15b. The “b” allele 
generally occurred at low frequency among population. In contrast, from this study 
result, it was also found that HPA-1b occurred more commonly among Indians 
compared with Malay and Chinese. HPA-4b homozygous individual was identified in 
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Malays among other who has no heterozygous HPA-4a/4b individual in Chinese and 
Indian (Tan et al., 2012).  
Platelets originate from bone marrow megakaryocytes by fragmentation of the 
cytoplasm. Megakaryocytes are the largest cells in the body. Each megakaryocyte can 
form approximately 1,000 to 5,000 platelets by fragmentation process. The maximum 
normal shelf life of platelet in bloodstream is 10 days. However, shorten quiescent state 
of platelets might be due to platelets that are primed to undergo explosive activation 
after any vessel wall injured and damaged or any pathogenesis disease involved 
(Cardigan et al., 2005). Besides, the platelet lifespan is also determined by the ratio of 
apoptotic BAX and anti-apoptotic BCL-2 proteins in the cell (Hoffbrand and Moss, 
2015). Due to the uniqueness of cell morphology like the shape and small size, it 
enables platelet to access the edge of blood vessels and constantly to survey vascular 
integrity. 
1.1.2 Platelet functionality  
Once vessel wall integrity is compromised and subendothelial components are exposed, 
this will activate platelets in response to bleeding. There are three major platelet 
functions response to bleeding, which are adhesion, aggregation, and release reaction 
and amplification. Adhesion is the first initial step to create platelet-collagen interaction 
on the vessel wall for platelet immobilization once shedding has occurred. It is mediated 
through VWF in plasma which acts as bridge between collagen from vessel wall and 
glycoprotein GPIb/IX/V complex on the platelet surface. With the initial complex 
formed, this will slow down the blood flow and enable platelets to enroll and stick on 
the damaged area of the vessel wall. Subsequently, platelet receptor GPIa/IIa and GPVI 
will directly bind with collagen to form firm adhesion. Apart from binding to collagen, 
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platelet also bind to other subendothelial matrix protein such as fibrinogen to initiate 
adhesion process. Primary activation also induces subsequent platelet activation via 
various signal transduction pathways by elevating calcium levels in cytoplasmic, cause 
cytoskeletal change, platelet’s shape change into pseudopod formation and platelet 
spreading. At the same time, granule components for instances serotonin, ADP and 
VWF are released by platelet intracellular to promote and amplify platelet recruitment, 
activation, aggregation and plug stabilization. Thromboxane which is the enzyme 
synthesis by platelet is important in secondary amplification of platelet activation to 
form a stable platelet aggregate and also promote vasoconstrictive activity (Cardigan et 
al., 2005;  Hoffbrand and Moss, 2015). 
Aggregation is characterized by cross link reaction between adjacent platelet receptor 
GPIIb/IIIa with VWF and fibrinogen bridges. After platelet aggregation and release 
reaction promoted, phospholipid on the outer membrane of the platelet will change into 
negative charge. This will enhance the binding sites for several coagulation complexes 
and promote coagulation cascade to form stable fibrin in secondary haemostasis 
(Cardigan et al., 2005;  Hoffbrand and Moss, 2015). Deficiencies in the number and/or 
function of platelets may cause abnormalities in coagulation pathway and increase risk 
of bleeding. Therefore, platelet transfusion is required to treat or prevent haemorrhage 
in patients with thrombocytopenia or platelet malfunction e.g. Glanzmann´s 
thrombasthenia, Bernard-Soulier syndrome, Chédiak-Higashi syndrome and 
Hermancky-Pudlak syndrome (Cardigan et al., 2005). To ensure successful treatment 
and good haemostatic function achieved by recipient, good quality and functionality of 
PCs product used for transfusion should be well preserved (Tynngård, 2009). 
Transfusion medicine is not a laboratory-based discipline but more likely clinical 
oriented specialty which requires to ensure safe transfusion process from donor’s vein 
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to patient’s vein. This process involves blood collection, blood component processing, 
storage, testing, transfusion, and monitoring on patient transfusion outcome. There are 
several guidelines being referred for processing blood components, such as National 
Blood Centre (NBC) Guideline, American Association of Blood Banks (AABB) 
Guideline, International Society of Blood Transfusion (ISBT) Guideline, and others. 
According to each guideline, platelet concentrates (PCs) can be obtained through 3 
different methods which are automated process of apheresis (AP), from WB donation 
via centrifugation using the platelet-rich plasma (PRP) method and from WB via buffy 
coat (BC) method. For the WB collection, 2 difference mixing methods can be 
employed which include manual mixing with scale and by using automated blood 
collection mixer. Uneven mixing process between citrate and blood immediately in 
primary bag will cause inadequate anticoagulation to react with cells component, 
resulting in decrease of labile coagulation factors, loss of quality for platelets and form 
of clumps that consist of erythrocytes, platelets, and some leucocytes (Amin et al., 
2016;  Armstrong, 2008;  Carson et al., 2011). Therefore, mixing process during blood 
collection is important to ensure anticoagulant in blood bag will mix evenly and 
adequately with the collected blood. However, there was only scanty published data on 
this topic. Hence, a study to look at the quality of PCs collected using two types of 
mixing method either through manually or by using automated blood collection mixer is 
needed to ensure that the platelet product transfused meets the standard quality control 
and is effective in treating patient requiring platelet transfusion (Amin et al., 2016;  
Armstrong, 2008;  Carson et al., 2011). 
Quality control (QC) of PCs is the tool available to assess component quality result and 
play as troubleshooting references to adjust production techniques when necessary. 
There are several methods that can be performed to assess the quality of PCs which are 
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tests of platelet function and metabolism in vitro, animal models of thrombocytopenia, 
recovery and survival of labeled autologous platelets in normal volunteers and platelet 
increment studies in thrombocytopenic patients (Cardigan and Williamson, 2003). 
However, platelet function tests are not easy to perform but also time-consuming, 
difficult to control test quality, lack sensitivity and usually require specialist laboratory 
support (Cardigan et al., 2005). In this study, only 3 parameters of platelet QC which 
are total platelet count, total white blood cells (TWBC) and pH will be assessed as per 
recommendation from NBC Guideline (Amin et al., 2016). 
1.2  Research Justification 
This study shall compare any significant difference on quality of PCs collected from 
two different mixing methods of blood collection which are manual mixing and 
automated blood collection mixer. 
The rationales of this study are: 
(1) To conduct first validation study on automated blood collection mixer, Bag 
Mixer BIO33, Italy based on quality of PCs produce. 
(2) To evaluate whether manual mixing method produces similar quality of PCs 
with automated blood collection mixer. 
(3) To conduct first study in Malaysia regarding comparison of PCs quality 
collected from two different mixing methods which are manual mixing and 
automated blood collection mixer. 
 
 
 7 
 
1.3  Objectives 
General Objective 
To study the quality of PCs collected from two different mixing methods which are 
manual mixing and automated blood collection mixer. 
Specific Objectives 
1. To determine the PCs quality which are total platelet count, TWBC and 
pH collected from two different mixing methods: manual mixing and 
automated blood collection mixer. 
2. To determine the changes of PCs quality which are total platelet count, 
TWBC and pH over 5 days of storage collected from two different 
mixing methods: manual mixing and automated blood collection mixer. 
3. To compare the quality of PCs which are total platelet count, TWBC and 
pH collected from two different mixing methods: manual mixing and 
automated blood collection mixer. 
1.4  Hypothesis 
Study Hypothesis 
There is a difference between quality of PCs which are total platelet count, TWBC and 
pH collected from two different mixing methods: manual mixing and automated blood 
collection mixer. 
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CHAPTER 2 
LITERATURE REVIEW 
2.1  Platelet concentrates collection methods 
2.1.1 Apheresis (AP) 
As per ISBT guideline, for AP procedure, the blood from the donor is processed with a 
cell separator with an in-line centrifuge for platelet collection. The platelets are 
transferred to a collection bag, whereas the other blood cells and most of the plasma are 
returned to the donor. Various cell separators are available for platelet collection and 
have different collection principles which are intermittent-flow and continuous flow. 
Whole AP blood donation usually requires about 2 hours (J.Hardwick, 2008). Based on 
NBC Guidelines, AP donor shall have to fulfill the standard criteria as per whole blood 
(WB) donor selection criteria and usually they are converted from regular WB donor 
(more than 5 times WB donation) with good vein. AP donor is allowed a maximum 
donation of total volume of 15 liters platelet and/or plasma in 24 times, in a year time. 
AP donor shall be subjected to have minimum interval of 2 weeks rest time between 
successive donation. The minimum pre-donation platelet count for a prospective platelet 
AP donor must be more than 150 x 109/L. The PRP and BC methods require pooling of 
platelets from several donors (usually 4-6) to obtain a platelet dose equivalent to that 
which can be obtained from a single donor by AP collection.  The yield of the platelets 
count in a bag is more than 200 x 109/unit, standard adult therapeutic dose (Amin et al., 
2016). Since only one donor is required to produce a transfusion unit by AP technique, 
the risk for HLA antigens alloimmunization is reduced as the recipient in this case is 
exposed to less antigen stimulation. Besides, this method also limits the risks of 
transfusion transmission infections expose to recipient. AP platelet is the first-choice 
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platelet product use for transfusion, however, the limitations are high producing cost 
involved and high technology cell separator required (J.Hardwick, 2008). Therefore, not 
every institute can afford to have AP technology to collect PCs.  
2.1.2 Whole blood collection by manual mixing and automated mixing 
Platelets derived from WB is another product commonly used for transfusion. WB is the 
source material for blood component preparation such as packed red blood cell (RBC), 
fresh frozen plasma (FFP) and PCs. Among three components obtained from a unit of 
WB collected, platelets are the most extremely labile, very easily activated and it’s 
quality easily affected during sample collection and processing (Greening et al., 2011). 
During WB collection, it is important to ensure the blood is adequately mixed with 
anticoagulant from the time it starts entering the primary bag. Mixing is important to 
prevent platelet consumption and clotting factor activation (Van Der Meer and Pietersz, 
2006). Low platelet count in PCs and low levels of coagulation factors including factor 
VIII in FFP can be the major negative consequences if inadequate mixing of WB with 
anticoagulant which subsequently cause the initiation of coagulation process in WB 
collected (Armstrong, 2008). 
During blood donation, approximately 450mL of WB from each donor is collected 
directly into bag containing CPD (citrate, phosphate and dextrose) anticoagulant, to 
prevent the blood from clotting. Citrate binds to calcium, and therefore it prevents the 
activation of clotting factors and thus clot formation. Citrate is the most commonly used 
anticoagulant in blood component collection (Green et al., 2015). According to ISBT 
guideline and NBC guideline, there are two methods use to mix the anticoagulant with 
the WB in primary bag which are manual mixing, immediately and continuously 
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upside-down of the bag on the scale every 30 seconds during donation and by using 
automated blood collection mixer (Armstrong, 2008;  Amin et al., 2016). 
Blood collection mixer had been developed to automate several steps in the blood-
collection process. The bags of the blood collection system are placed in the mixer, and 
once the vein is punctured, the device mixes the blood with the anticoagulant. 
Automatic mixer measures and checks the volume of blood collected according to type 
of blood bag used along the donation process. Once the desired volume is collected, the 
mixer automatically clamps the donation tubing to prevent overfilling of the bag. The 
ratio between volume of blood collected and volume of anticoagulant in the bag should 
be correct. Overweight blood bag indicates insufficient anticoagulant reacts with blood 
collected and this may lead to initiation of clotting process. Underweight blood bag 
means there is an excessive anticoagulant within blood collected which could denatures 
the blood properties during storage. Underweight and overweight blood collection are 
not suitable for transfusion and usually will be discarded. Besides, mixer measures the 
flow speed, and can be programmed to sound an alarm when the blood flow falls below 
a predetermined level. The duration of the donation is very important to prevent 
initiated coagulation especially during slow flow. PCs cannot be processed if the 
duration of donation was longer than 12 minutes. Furthermore, FFP and cryoprecipitate 
cannot be produced if donation took longer than 15 minutes. Hence, it was important to 
record the donation duration (Van Der Meer and Pietersz, 2006;  Armstrong, 2008). 
Besides, mixing the collected blood with anticoagulant, blood collection mixer also 
measured the volume donation accurately and monitored the blood flow rate and time 
taken for the donation. However, there are some limitations by using blood collection 
mixer which are high cost of the equipment, approximately 5 times higher than scale 
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and practical difficulties in terms of difficult for transportation, battery loading and the 
bulky size of the mixer (Follea et al., 1997).  
In the absence of an automated blood collection mixer, the bag should be hung upside 
down on the scale to allow the inflowing blood mix with the anticoagulant immediately 
upon entering the bag. The content of the collection bag should be manually mixed 
every 30 second throughout the collection period. There is risk for inadequate mixing 
process with anticoagulant in primary bag if WB is collected manually using scale 
(Armstrong, 2008;  Amin et al., 2016). 
In late 19 centuries, G.Follea et al. conducted a similar study regarding comparative 
manual and automated methods for mixing and volume control in WB collection. Three 
different brands of automated blood collection mixers which were Compomixer (NPBI, 
Germany), Optimix (Baxter, Belgium) and Hemo-matic (Hemopharm, France) were 
used to compare with manual scale in the study. The study showed that manual or the 
automated mixing procedures had equal accuracy and reproducibility of the blood 
volumes obtained, collection times and flow rates. The quality of all these products 
including red blood cell concentrates, PCs and plasma units collected from automated 
procedures were found to be comparable to that manual procedure. The study concluded 
that there was no significant advantage from the use of automated blood collection 
monitors as compared to simple scale with manual mixing method at that upon of time 
(Follea et al., 1997). 
Another study by De Korte D and Veldman HA in 2001 showed that certain blood 
mixing devices failed to mix effectively, especially at low bleeding rates. Manual 
mixing of the collection containers showed sufficient mixing of WB with anticoagulant 
compared to blood collection mixer (de Korte and Veldman, 2001).  
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Subsequently, another evaluation study on automated blood collection mixers with 
latest improvement features were done by P. F. van der Merr and & R.N. Pietersz, in 
2006. Two different brands of automated blood collection mixers which were 
CompoGuard (Fresenius Hemocare, Netherlands) and HemoLight (Fresenius Kabi AG, 
Germany) were evaluated in the study. The result showed that CompoGuard blood 
collection mixer gave sufficient mixing at low flow rate (30 mL/min), normal flow rate 
(60mL/min) and high flow rate (90 mL/min). HemoLight only able to mix well at 
normal and high flow rate. However, the overall mixing results obtained from this study 
showed great improvement compared with the similar study done before by De Korte D 
and Veldman HA in 2001. This study suggested that the quality of blood collection 
mixers had improved over the year (Van Der Meer and Pietersz, 2006).  
2.2  Platelet concentrates derived from whole blood 
2.2.1 Platelet rich plasma (PRP) method  
Platelets derived from WB are produced by the PRP method in the USA, whereas the 
BC method is used in Europe and Canada (Vassallo and Murphy, 2006). Both PRP and 
BC methods are used to separate blood components from WB based on principle of 
centrifugation; each cellular has different size and density properties. This will make 
each cellular sediment at different rates when centrifugal force is applied. Red cells 
have greater mass and highest density, it will settle at the bottom of the blood bag. 
Whereas, white cells will sediment above the red cells, platelet form a layer above the 
white cells and leave the plasma and anticoagulant at the top of suspending fluid 
(J.Hardwick, 2008). 
PRP method involved soft spin centrifugation to obtained PRP followed by a high-
speed centrifugation to obtain a platelet poor plasma and platelet pallet (J.Hardwick, 
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2008). Most of the plasma is removed, and the platelets are stored in a reduced volume 
of remaining plasma. Alternatively, the platelets are re-suspended in a synthetic medium 
such as platelet additive solution (PAS) (Ringwald et al., 2012). The critical step in the 
production of PCs by using PRP method is the validated first soft centrifugation at a 
speed and time needed to maximize the number of platelets, and minimize the number 
of red cells and leucocytes in plasma. The most challenge step using PRP method to 
produce PCs is removal of buffy coat from red cell concentrates after soft-spin, as the 
interface between these 2 components are not sharply defined (J.Hardwick, 2008). 
Furthermore, if the second centrifugation is performed too hard, the platelet button will 
form the stubborn aggregated platelets in the bottom of the bag. This will make 
irreversible platelet aggregation in PCs and significantly compromised the PCs quality 
produced (Ringwald et al., 2014). 
2.2.2 Buffy coat (BC) method  
There are two methods to prepare BC which are conventional quad bag method and top 
and bottom bag method. With the BC processing method, WB is centrifuged at high-
speed to prepare a BC. The BCs are pooled and centrifuged to a platelet-rich 
supernatant that is transferred to the storage container. The critical step to produce a 
high number of platelets with low white and red cells count in PCs by BC method is the 
validated second centrifugation setting. It is important to sediment the residue red cells 
and white cells whereas maximized platelet remain suspended in plasma as supernatant. 
Besides, due to the volume of BC is small, the bag fails to insert and sit vertically in 
centrifuge bucket and this will cause pockets cells trapped in the fold. This will 
interface between residue red cells and PRP after centrifugation. Proper supports like 
special plate or dummy bag shall be inserted to withstand the BC in the centrifuge 
bucket (J.Hardwick, 2008). 
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2.2.3  Comparison between platelet concentrates produced by three different 
processing methods  
The selection of PCs preparation methods should be based on each institution 
availability of resource and efficacy. There is substantial variability of QC of the 
products due to the different preparation methods. In the study of RP Singh et al. 
(2009), there was no significant different in terms of platelet count per unit, swirling 
score and pH between platelet rich plasma derived platelet concentrates (PRP-PC) and 
buffy coat poor derived platelet concentrates (BC-PC) units. However, BC-PC had been 
found less white blood cell contamination compared with PRP-PC unit. AP-PC units 
showed better swirling score and platelet count than PRP-PC and BC-PC units (Singh et 
al., 2009). Besides, apheresis derived platelet concentrates (AP-PC) units contained less 
WBC contamination compared with PRP-PC and BC-PC units. The study suggested 
that the quality of AP-PC was superior than PRP-PC and BC-PC. AP-PC may be 
recommended and indicated only in selected patients or HLA-matched platelet 
transfusion (Singh et al., 2009). Another study was done by RS Mallhi et al., in year 
2015, also found that quality of AP-PC was better than BC-PC. However, one AP-PC 
unit cost approximately five to six times higher than 6 BC-PC units. AP-PC should be 
reserved for more deserving multi-transfused immunocompromised patients and HLA-
matched/HPA-matched/crossmatched platelet transfusion are indicated (Mallhi et al., 
2015). 
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2.3  Storage Requirement 
The shelf life of PCs varies between 3 and 7 days, accordingly to local regulatory 
authorities enforcement. Malaysia is practicing maximum 5 days shelf life of the PCs 
used for transfusion (Amin et al., 2016). PCs are stored at room temperature (20⁰C to 
24⁰C) with constantly agitating. It is necessary to maintain platelet viability during 
storage.  
2.3.1  Storage lesion 
Storage at 20⁰C to 24⁰C is susceptible in promoting bacteria growth and increase the 
risk of bacterial contamination in PCs. Therefore, short shelf life of the PCs was implied 
(Tynngård, 2009). There are many factors influence the quality of platelets during 
storage which include PCs preparation method, type of plastic material used for storage 
bag, permeability of the bag surface to allow gas exchange, storage temperature, type of 
anticoagulant used, total volume of the PCs in the bag and the motion of agitation 
(Murphy and Gardner, 1975;  Slichter and Harker, 1976). Theoretically, every 
manipulation of platelets may lead to the activation or apoptosis of the cells. Platelets 
exposure to plastics, centrifugation, filters, gases, solution and temperature changes may 
create a stress, leading to alterations (Garraud et al., 2016). This is commonly defined 
as storage lesion where changes that alter the physiological properties in collected blood 
over time. Platelets lose their functionality and viability during in vitro storage and are 
not suitable to use for treatment of patient who requires platelet therapy (J.Hardwick, 
2008).  
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2.3.1.1 Storage temperature 
Decrease storage temperature will increase platelet stickiness and lead to aggregation. In 
1967, Pert et al., showed more clumping in PCs from chilled blood compared with the 
blood kept at room temperature (Pert et al., 1967). In 1971, another study done by 
Kattlove et al., reported higher aggregation tendency from PCs prepared from blood 
stores at low temperatures (0⁰C to 6⁰C) than blood kept at 23⁰C and 37⁰C. From the 
study, they postulated that low temperature may cause conformational changes in 
platelet membrane protein and induced aggregation (Kattlove and Alexander, 1971). In 
a study conducted by Welch et al., in 1985, result showed number of platelet clumps 
reduced when the temperature of centrifuge and storage environment increased from 
20⁰C to 24⁰C (Welch and Champion, 1985). As per discussed above, platelet 
aggregation may increase due to lower temperature exposure. Therefore, PCs shall 
always process and keep in optimal storage temperature 20⁰C to 24⁰C. 
2.3.1.2 Storage container 
PCs shall be kept in good bag container, to ensure proper gas exchange throughout 5 
days lifespan. The most common problem with platelet container is lack efficiency of 
gas permeability and exchangeability from the surface of the container. If platelets are 
in hypoxia condition, this will lead to increase platelet glycolysis and increase lactate 
acid production. Subsequently, this will induce low pH value and ATP level, and cause 
insufficient energy supply (Gulliksson et al., 1992). Hence, changes in pH in PCs 
indicate significant defect on platelet viability. First-generation storage bag made of 
polyvinyl chloride (PVC) plasticized with di(2-ethylhexyl)phthalate had poor oxygen 
permeability and therefore PCs only compromised for 3 days storage. With 
improvement, second-generation storage bags produced by different material which is 
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polyolefin (Murphy et al., 1982) and PVC plasticized with tri(2-ethylhexyl) trimellitate 
(Simon et al., 1983) which had greatly increased on gas permeability and allowed the 
storage period to be extended to 5 days. Furthermore, PVC plasticized from butyryl-tri-
n-hexyl-citrate have shown good gaseous permeability and good in vivo viability of 
platelets upon transfusion (Turner et al., 1995). 
2.3.1.3 Overloading platelet  
Overloading platelet contents in storage container will cause increased capacity of 
oxygen transportation from storage container which leads to immediate negative effects 
on platelet metabolism and energy supply. This will cause delayed effects on platelet 
function and some platelet disintegration (Gulliksson et al., 2012). Another factor that 
could potentially cause loss of viability by storage of PCs in volume less than 35mL. 
Lesser platelets volume will increase container surface-to-PC volume ratio and lead to 
more frequent platelet container wall interaction and cause platelet activation (Singh et 
al., 2009). A study done by Bode et al. (1989) showed that it was important to reduce 
container surface area-to volume ratio from 7cm2 to 4cm2, to prevent less platelet 
activation during storage (Bode and Miller, 1989). By reducing this factor, less lactate 
produced, platelet morphological and function integrity were greatly improved during 
storage (Bode and Miller, 1989). 
2.3.1.4 Duration of storage 
It is known that the metabolic activity of platelets continues throughout storage and 
even with all the procedures have been taken to preserve platelet haemostatic viability. 
A study done by Maria et al. (2011) showed throughout storage of PCs for 5 days, 
platelet aggregation decreased with storage whereas platelet count and pH increased 
with storage (Maria José Dantas et al., 2011).   
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Similarly, another study showed that Day 6 samples platelet yield/unit and pH value 
were higher than Day 1 samples. Day 1 samples indicated low CD62P expression 
compared with Day 5 samples. This showed most of the platelets were undergo 
degranulation and activation at Day 5 (Mastronardi et al., 2013). The study result also 
implied slightly reduction of morphology score and percentage of extent shape change 
(ESC) for Day 1 sample compared with Day 5 sample (Mastronardi et al., 2013). 
Another study done showed increase in percentage of platelet expressed CD62P, 20-
30% at Day 4/5 to 30-50% at Day 7/8 (Dumont et al., 2002). There was a 30% 
decreased in the ESC between Day 1 and Day 7 of PCs stored in plasma (Holme et al., 
1990). Another study also showed 20%-45% decreased in platelet morphology score 
between Day 1 and Day 7 storage (Dumont et al., 2002). By decreased morphology 
score and ESC, platelets showed loss of discoid shape and poor recovery and survival 
rate in vivo (Holme et al., 1978). 
2.4  References guidelines for platelet concentrates quality requirement 
QC parameters that were used for assessment of PCs included swirling, volume, platelet 
count and white blood cell count per bag and pH change. There were few international 
guidelines that can be referred to determine quality requirement and specification of 
platelet components produced (Amin et al., 2016;  Carson et al., 2011;  WHO, 2002;  
Europe, 2015). 
In Malaysia, minimum quality requirements of random PCs are platelet count more than 
60 x 109/ unit, volume remain 50mL to 70mL, TWBC count less than 0.2 x 109/ unit 
prepared from PRP method, TWBC count less than 0.05 x 109/ unit prepared from BC 
method, pH more than 6.4 and sterility test detect no microorganism growth (Amin et 
al., 2016). 
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Summary of parameters for assessment of PCs quality from different guidelines are 
shown in table 2.1 (Amin et al., 2016;  Carson et al., 2011;  WHO, 2002;  Europe, 
2015). 
Table 2.1: Summary of platelet concentrates quality requirement from different 
guidelines 
     Parameters 
 
 
 
Guidelines 
 
Platelet 
Count 
WBC Count pH Sterility Volume 
 
Acceptance 
Range of 
% Tested 
Products 
to Meet 
Criteria 
NBC  
 
 
 
PRP method: 
 
BC method: 
60 x 
109/unit 
  
 
 
 
<0.2 x 109/unit 
 
<0.05 x 
109/unit 
> 6.4 No 
growth 
50-
70mL 
75% for 
other 
testing 
parameters 
except for 
total white 
blood cell 
count 
 
90% for 
total white 
blood cell 
count 
 
AABB  
 
 
Pool platelets 
leucocytes 
reduced: 
 
single filtrated 
PC: 
55 x 
109/unit 
 
 
 
<5 x 106/unit 
 
 
 
<8.3 x 105/unit 
 
> 6.2 No 
growth 
40-
70mL 
90% for 
total 
platelet 
count and 
pH 
 
95% for 
total white 
blood cell  
 
WHO 55 x 
109/unit 
<0.12 x 
109/unit 
Not 
specify 
Not 
specify 
50-
60mL 
 
Not Specify 
Council of 
Europe  
 
 
 
60 x 
109/unit 
 
 
 
 
 
> 6.4 Not 
specify 
50-
70mL 
75% for 
total 
platelet 
count  
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     Parameters 
 
 
 
Guidelines 
 
Platelet 
Count 
WBC Count pH Sterility Volume 
 
Acceptance 
Range of 
% Tested 
Products 
to Meet 
Criteria 
PRP method: 
 
BC method: 
<0.2 x 109/unit 
 
<0.05 x 
109/unit 
90% for 
total white 
blood cell 
count 
 
 
2.5  Quality control of platelet concentrates 
2.5.1 Total platelet count 
Platelet count is the total number of platelets exist in the final storage bag. Platelet count 
is not only interfered by platelet metabolism activity throughout storage but also with all 
procedures that allow platelet haemostatic viability (Seghatchian and Krailadsiri, 2000;  
J.Hardwick, 2008). Platelet count is an important assessment required to perform and to 
check sufficient cells content in PCs. Low platelet yield in PCs will cause ineffective 
platelet increment post transfusion (Maria José Dantas et al., 2011). 
2.5.2 Total white blood cell  
Leucocytes contamination in PCs compete for available oxygen and this will result in 
giving negative effects on platelet metabolism, increase glucose consumption, decrease 
energy supply, increase lactic acid production, significant decrease in pH value, but also 
delayed effects on platelet function and some platelet disintegration (Gulliksson et al., 
2012;  Cardigan and Williamson, 2003). High concentration of leucocytes in 5 days 
storage of PCs will cause high excretion of β-TG, loss of platelet nucleotides, decreased 
ability to incorporate H-adenosine and poor platelet morphology (Saran, 2003;  Pietersz 
